跳到主要內容

Gibson Christopher 的 Form 4 申報

Recursion Pharmaceuticals, Inc.(RXRX),2023/5/5 申報

申報編號
0001209191-23-027830
申報時間
2023/5/5
交易日
2023/1/5-5/3
申報延遲
120 天遲報
10b5-1 計畫
沒有勾選

這份申報列了 17 筆非衍生性交易、8 筆衍生性交易。公開市場賣出合計 $27.8 萬。交易後 120 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Gibson ChristopherCIK 0001856369董事、高階主管(執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/1/5Class A Common StockC轉換取得+3,000$0.00$0966,710直接
2023/1/5Class A Common StockG贈與處分−3,000$0.00$0963,710直接
2023/2/2Class A Common StockC轉換取得+3,000$0.00$0966,710直接
2023/2/2Class A Common StockG贈與處分−3,000$0.00$0963,710直接
2023/3/2Class A Common StockC轉換取得+3,000$0.00$0966,710直接
2023/3/2Class A Common StockG贈與處分−3,000$0.00$0963,710直接
2023/5/3Class A Common StockG贈與處分−8,662$0.00$0955,048直接
2023/5/3Class A Common StockC轉換取得+1,338$0.00$0956,386直接
2023/5/3Class A Common StockG贈與處分−1,338$0.00$0955,048直接
2023/5/3Class A Common StockM行使選擇權取得+31,250$2.48+$77,500986,298直接
2023/5/3Class A Common StockS賣出處分−33,073$4.71F5−$155,773.83953,225直接
2023/5/3Class A Common StockC轉換取得+4,000$0.00$04,000間接
2023/5/3Class A Common StockS賣出處分−4,000$4.91F7−$19,6400間接
2023/5/3Class A Common StockC轉換取得+20,000$0.00$020,000間接
2023/5/3Class A Common StockS賣出處分−20,000$4.90F7−$98,0000間接
2023/5/3Class A Common StockC轉換取得+1,000$0.00$01,000間接
2023/5/3Class A Common StockS賣出處分−1,000$4.92F10−$4,9200間接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2023/5/3Class A Common StockM行使選擇權處分−31,250$0.00$0625,000直接
2023/1/5Class A Common StockC轉換處分−3,000$0.00$06,558,834直接
2023/2/2Class A Common StockC轉換處分−3,000$0.00$06,555,834直接
2023/3/2Class A Common StockC轉換處分−3,000$0.00$06,552,834直接
2023/5/3Class A Common StockC轉換處分−1,338$0.00$06,551,496直接
2023/5/3Class A Common StockC轉換處分−4,000$0.00$0531,000間接
2023/5/3Class A Common StockC轉換處分−20,000$0.00$0488,000間接
2023/5/3Class A Common StockC轉換處分−1,000$0.00$0122,875間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F5

This transaction was executed in multiple trades at prices ranging from $4.55 to $5.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F7

This transaction was executed in multiple trades at prices ranging from $4.57 to $5.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 2 筆交易的價格引用這則附註。

F10

This transaction was executed in multiple trades at prices ranging from $4.64 to $5.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)